MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to CisplatinReportar como inadecuado

MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou 510055, China

These authors contributed equally to this work.


Author to whom correspondence should be addressed.

Abstract microRNAs have been shown to play critical roles in regulating the chemosensitivity of cancer cells. As a member of the oncogenic miRNAs oncomiRs, miR-222 has been reported to drive the oncogenesis of many types of malignancies. However, little is known concerning the specific role of miR-222 in human oral squamous cell carcinoma OSCC. The present study explored the role and mechanism of miR-222 in increasing the expression of p53 up-regulated modulator of apoptosis PUMA and enhancing the sensitivity of OSCC to cisplatin CDDP. Results showed that antisense As-miR-222 inhibits the expression of miR-222. In contrast, PUMA was dramaticallyup-regulated. IC50 values were significantly decreased in cells treated with As-miR-222 combined with CDDP, to a greater extent than in cells treated with CDDP alone. Furthermore, As-miR-222 enhanced apoptosis and inhibited the invasiveness of UM1 cells. Analysis of the above data suggested that, in UM1 cells, there might be a regulatory loop between miR-222 and PUMA, and that miR-222 inhibition increased the chemosensitivity to CDDP. These findings demonstrated that down-regulation of miR-222 could enhance the chemosensitivity of human OSCC cells to CDDP, and that the combination of As-miR-222 and CDDP could be an effective therapeutic strategy by boosting the expression of PUMA for controlling the growth of OSCC. View Full-Text

Keywords: OSCC; PUMA; miR-222; cisplatin OSCC; PUMA; miR-222; cisplatin

Autor: Fangfang Jiang †, Wei Zhao †, Lijie Zhou, Zifeng Liu, Wenqing Li and Dongsheng Yu *

Fuente: http://mdpi.com/


Documentos relacionados